NCBI National Center for Biotechnology Information |
2VIW: Fragment-based Discovery Of Mexiletine Derivatives As Orally Bioavailable Inhibitors Of Urokinase-type Plasminogen Activator | ||||||||||||||||||
* Click molecule labels to explore molecular sequence information.
|